Gelonghui, May 20 | Keqian Biology (688526.SH) announced that the company plans to use the capital raised from the initial fund-raising project “Animal Biological Products Workshop Technical Improvement Project” of 287 million yuan (the actual amount is subject to the balance of the special account raised after review and approval by the shareholders' meeting) for the new project “High-Level Animal Vaccine Industrialization Base Construction Project (Phase 1)”. The total planned investment amount for the new project is about RMB 600 million (the final total investment amount is based on actual investment).
科前生物(688526.SH)：拟将募集资金2.87亿元使用于新项目“高级别动物疫苗产业化基地建设项目(一期)”
Ke Qian Biology (688526.SH): Plans to use the raised capital of 287 million yuan for the new project “High-Level Animal Vaccine Industrialization Base Construction Project (Phase I)”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.